Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural biology of complement receptors. | Front Immunol | 2023 | 37753090 | PubTator, text mining | PubMed |
| Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37752146 | PubTator, text mining | PubMed |
| Oral squamous cell carcinomas: state of the field and emerging directions. | Int J Oral Sci | 2023 | 37736748 | PubTator, text mining | PubMed |
| The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy. | MedComm (2020) | 2023 | 37719444 | PubTator, text mining | PubMed |
| The functions and clinical application potential of exosomes derived from mesenchymal stem cells on wound repair: a review of recent research advances. | Front Immunol | 2023 | 37691943 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions. | Clin Transl Med | 2023 | 37691350 | PubTator, text mining | PubMed |
| High-precision targeting and destruction of cancer-associated PDGFR-β+ stromal fibroblasts through self-assembling, protein-only nanoparticles. | Acta Biomater | 2023 | 37683965 | PubTator, text mining | PubMed |
| Bioinformatics-based and multiscale convolutional neural network screening of herbal medicines for improving the prognosis of liver cancer: a novel approach. | Front Med (Lausanne) | 2023 | 37680619 | PubTator, text mining | PubMed |
| SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. | J Clin Invest | 2023 | 37655663 | PubTator, text mining | PubMed |
| Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 37628831 | PubTator, text mining | PubMed |
| Overview of miR-106a Regulatory Roles: from Cancer to Aging. | Bioengineering (Basel) | 2023 | 37627777 | PubTator, text mining | PubMed |
| Pericytes and vascular smooth muscle cells in central nervous system arteriovenous malformations. | Front Physiol | 2023 | 37601628 | PubTator, text mining | PubMed |
| DNA methylation mediated genetic risk in severe acne in a young men population. | Front Med (Lausanne) | 2023 | 37554505 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells. | BMC Ophthalmol | 2023 | 37537538 | PubTator, text mining | PubMed |
| The Effects of DDI1 on Inducing Differentiation in Ovine Preadipocytes via Oar-miR-432. | Int J Mol Sci | 2023 | 37511326 | PubTator, text mining | PubMed |
| H3G34-Mutant Gliomas-A Review of Molecular Pathogenesis and Therapeutic Options. | Biomedicines | 2023 | 37509641 | PubTator, text mining | PubMed |
| Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures: A Narrative Review. | Biomedicines | 2023 | 37509560 | PubTator, text mining | PubMed |
| Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil. | Clin Transl Med | 2023 | 37491740 | PubTator, text mining | PubMed |
| Effector Genes at the Coronary Artery Disease Risk Locus Harboring PDGFD and LncRNA AP002989.1. | J Am Heart Assoc | 2023 | 37489770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=7